Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Morena

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Clinical Lipidology|April 11, 2017
Plasma PCSK9 concentrations during the course of nondiabetic chronic kidney disease: Relationship with glomerular filtration rate and lipid metabolismMarion Morena, Cédric Le May, Leila Chenine, et al.
Plos One|May 9, 2012
Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patientsMarion Morena, Isabelle Jaussent, Aurore Halkovich, et al.
Journal of the American Society of Nephrology : JASN|November 11, 2005
Plasma osteoprotegerin is associated with mortality in hemodialysis patientsMarion Morena, Nathalie Terrier, Isabelle Jaussent, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2015
Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcificationsMarion Morena, Isabelle Jaussent, Anne-Marie Dupuy, et al.
Molecular Pharmaceutics|July 2, 2016
Functionalized Mesoporous Silica Nanoparticle with Antioxidants as a New Carrier That Generates Lower Oxidative Stress Impact on CellsRaymond Ebabe Elle, Saher Rahmani, Céline Lauret, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 9, 2021
Skeletal Muscle Phenotype in Patients Undergoing Long-Term Hemodialysis Awaiting Kidney TransplantationJean-Sébastien Souweine, Fares Gouzi, Éric Badia, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 19, 2020
Long-term effects of citric acid-based bicarbonate haemodialysis on patient outcomes: a survival propensity score-matched study in western FranceJacky Potier, Thibault Dolley-Hitze, Didier Hamel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2008
Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determinationStéphanie Badiou, Jean-Paul Cristol, Isabelle Jaussent, et al.
Journal of Nephrology|September 8, 2012
Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patientsAnne-Sophie Bargnoux, Jean-Paul Cristol, Isabelle Jaussent, et al.
Blood Purification|July 5, 2018
Continuous Veno-Venous High Cut-Off Hemodialysis Compared to Continuous Veno-Venous Hemodiafiltration in Intensive Care Unit Acute Kidney Injury PatientsSanjeet Balgobin, Marion Morena, Vincent Brunot, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Lipidology|April 11, 2017
Plasma PCSK9 concentrations during the course of nondiabetic chronic kidney disease: Relationship with glomerular filtration rate and lipid metabolismMarion Morena, Cédric Le May, Leila Chenine, et al.
Plos One|May 9, 2012
Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patientsMarion Morena, Isabelle Jaussent, Aurore Halkovich, et al.
Journal of the American Society of Nephrology : JASN|November 11, 2005
Plasma osteoprotegerin is associated with mortality in hemodialysis patientsMarion Morena, Nathalie Terrier, Isabelle Jaussent, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2015
Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcificationsMarion Morena, Isabelle Jaussent, Anne-Marie Dupuy, et al.
Molecular Pharmaceutics|July 2, 2016
Functionalized Mesoporous Silica Nanoparticle with Antioxidants as a New Carrier That Generates Lower Oxidative Stress Impact on CellsRaymond Ebabe Elle, Saher Rahmani, Céline Lauret, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 9, 2021
Skeletal Muscle Phenotype in Patients Undergoing Long-Term Hemodialysis Awaiting Kidney TransplantationJean-Sébastien Souweine, Fares Gouzi, Éric Badia, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 19, 2020
Long-term effects of citric acid-based bicarbonate haemodialysis on patient outcomes: a survival propensity score-matched study in western FranceJacky Potier, Thibault Dolley-Hitze, Didier Hamel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2008
Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determinationStéphanie Badiou, Jean-Paul Cristol, Isabelle Jaussent, et al.
Journal of Nephrology|September 8, 2012
Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patientsAnne-Sophie Bargnoux, Jean-Paul Cristol, Isabelle Jaussent, et al.
Blood Purification|July 5, 2018
Continuous Veno-Venous High Cut-Off Hemodialysis Compared to Continuous Veno-Venous Hemodiafiltration in Intensive Care Unit Acute Kidney Injury PatientsSanjeet Balgobin, Marion Morena, Vincent Brunot, et al.
Pageof 8